What non-prescription treatments do UK women with breast cancer use?

European Journal of Cancer Care

Volumn 15, Issue 3, 2006, Pages 279-285

  Catt, S ^a   Fallowfield, L ^a   Langridge, C ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Adherence; Breast cancer; Complementary and alternative medicine; Polypharmacy

Indexed keywords

ANTINEOPLASTIC AGENT; NON PRESCRIPTION DRUG;

AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST TUMOR; DRUG ADMINISTRATION; FEMALE; HUMAN; MIDDLE AGED; PATIENT ATTITUDE; PATIENT SATISFACTION; STATISTICS; UNITED KINGDOM; UTILIZATION REVIEW;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; DRUG ADMINISTRATION SCHEDULE; DRUGS, NON-PRESCRIPTION; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; NONPRESCRIPTION DRUGS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION;

EID: 33745901660     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00652.x     Document Type: Article

References (47)

1. Abbot N.C. & Ernst E. (1997) Patients' opinions about complementary medicine. Forschung Komplementarmedizin 4, 164-168.
2. Adler S.R. & Fosket J.R. (1999) Disclosing complementary and alternative medicine use in the medical encounter: qualitative study in women with breast cancer. Journal of Family Practice 48, 453-458.
3. Boon H. & Wong J. (2004) Botanical medicine and cancer: a review of the safety and efficacy. Expert Opinion on Pharmacotherapy 5, 2485-2501.
4. Branda R., Naud S.J., Brooks E.M., Chen Z. & Muss H. (2004) Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy-induced mucositis and neutropenia. Cancer 101, 1058-1064.
5. Burke C. & Sikora K. (1993) Complementary and conventional cancer care: the integration of two cultures. Clinical Oncology (Royal College of Radiologists) 5, 220-227.
6. Cassidy A. (2003) Are herbal remedies and dietary supplements safe and effective for breast cancer patients? Breast Cancer Research 5, 300-302.
7. Cassileth B.R. & Deng G. (2004) Complementary and alternative therapies for cancer. The Oncologist 9, 80-89.
8. Cheong J.L. & Bucknall R. (2005) Retinal vein thrombosis associated with a herbal phytoestrogen preparation in a susceptible patient. Postgraduate Medical Journal 81, 266-267.
9. Corbin Winslow L. & Shapiro H. (2002) Physicians want education about complementary and alternative medicine to enhance communication with their patients. Archives of Internal Medicine 162, 1176-1181.
10. D'Amico A.V., Toupless G., Lopes L., Valentine K.J., Cormack R.A., Tempany C.M., Kumar S. & Marks P.J. (2002) Self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. International Journal of Radiation Oncology, Biology, Physics 54, 1311-1313.
11. Datamonitor (2002) Datamonitor: Complementary and Alternative Medicine in Cancer Therapy. PublicationBFHC0462. Available at: http://www.datamonitor.com/ all/reports/ product_summary.asp?pid=BFHC0462 (published 30 June 2002, accessed on 23 March 2005).
12. Downer S.M., Cody M.M., McCluskey P., Wilson P.D., Arnott S.J. & Lister A. (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. British Medical Journal 309, 86-89.
13. Eisenberg D.M., Davis R.B. & Ettner S.L. (1998) Trends in alternative medicine use in the United States, 1990-97. Journal of the American Medical Association 280, 1569-1575.
14. Emslie M.J., Campbell M.K. & Walker K.A. (2002) Changes in public awareness of, attitudes to, and use of complementary therapy in North East Scotland: surveys in 1993 and 1999. Complementary Therapies in Medicine 10, 148-153.
15. Ernst E. (1998) Harmless herbs? A review of the recent literature. The American Journal of Medicine 104, 170-178.
16. Ernst E. (2000) Prevalence of use of complementary/alternative medicine: a systematic review. Bulletin of the World Health Organization 78, 252-257.
17. Ernst E. & Cassileth B.R. (1999) How useful are unconventional cancer treatments? European Journal of Cancer 35, 1608-1613.
18. Ernst E. & White A. (2000) The BBC survey of complementary medicine use in the UK. Complementary Therapies in Medicine 8, 32-36.
19. Fallowfield L., Atkins L., Morris R., Price M. & Langridge C. (2005) Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Annals of Oncology doi:10.1093/annonc/mdj044.
20. Featherstone C., Godden D., Selvaraj S., Emslie M. & Took-Zozaya M. (2003) Characteristics associated with reported CAM use in patients attending six GP practices in the Tayside and Grampian regions of Scotland: a survey. Complementary Therapies in Medicine 11, 168-176.
21. Henderson J.W. & Donatelle R.J. (2003) The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. PsychoOncology 12, 59-67.
22. Huntley A. (2004) Drug-herb interactions with herbal medicines for menopause. Journal of the British Menopause Society 10, 162-165.
23. Izzo A.A. & Ernst E. (2001) Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61, 2163-2175.
24. Kessler R.C., Davis R.B., Foster D.F., Van Rompay M.I., Walters E.E., Wilkey S.A., Kaptchuk T.J. & Eisenberg D.M. (2001) Long-term trends in the use of complementary and alternative medicine therapies in the United States. Annals of Internal Medicine 135, 262-268.
25. Lagman R. & Walsh D. (2003) Dangerous nutrition? Calcium, vitamin D, and shark cartilage nutritional supplements and cancer-related hypercalcemia. Support Care Cancer 11, 232-235.
26. Lee M.M., Lin S.S., Wrensch M.R., Adler S.R. & Eisenberg D. (2000) Alternative therapies used by women with breast cancer in four ethnic populations. Journal of the National Cancer Institute 92, 42-47.
27. McNaughton S.A., Mishra G.D., Paul A.A., Prynne C.J. & Wadsworth M.E.J. (2005) Supplement use is associated with health status and health-related behaviors in the 1946 British Birth Cohort. Journal of Nutrition 135, 1782-1789.
28. Mathijssen R.H., Verweij J., de Bruijn P., Loos W.J. & Sparreboom A. (2002) Effects of St. John's wort on irinotecan metabolism. Journal of the National Cancer Institute 94, 1247-1249.
29. Messerer M., Johansson S.E. & Wolk A. (2001) Sociodemographic and health behaviour factors among dietary supplement and natural remedy users. European Journal of Clinical Nutrition 55, 1104-1110.
30. Morris K.T., Johnson N., Homer L. & Walts D. (2000) A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. The American Journal of Surgery 179, 407-411.
31. Navo M.A., Phan J., Vaughan C., Palmer J.L., Michaud L., Jones K.L., Bodurka D.C., Basen-Engquist K., Hortobagyi G.N., Kavanagh J.J. & Smith J.A. (2004) An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. Journal of Clinical Oncology 22, 671-677.
32. Newman V., Rock C.L., Faerber S., Flatt S.W., Wright F.A. & Pierce J.P. (1998) Dietary supplement use by women at risk for breast cancer recurrence. Journal of the American Dietetic Association 98, 285-292.
33. Patel S. & Savage I. (2003) Unreported use of complementary medicines by community pharmacy prescription customers. The International Journal of Pharmacy Practice 11, R67.
34. Piersen C.E. (2003) Phytoestrogens in botanical dietary supplements: implications for cancer. Integrative Cancer Therapies 2, 120-138.
35. Rees R.W., Feigel I., Vickers A., Zollerman C., McGurk R. & Smith C. (2000) Prevalence of complementary therapy use by women with breast cancer: a population-based survey. European Journal of Cancer 36, 1359-1364.
36. Richardson M.A., Masse L., Nanny K. & Sanders C. (2004) Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer 12, 797-804.
37. Robertson J.F.R. (2005) Incidence of polypharmacy in patients with breast cancer. The Breast 14, S39.
38. Robinson A. & McGrail M.R. (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complementary Therapies in Medicine 12, 90-98.
39. Rockwell S., Liu Y. & Higgins S.A. (2005) Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Research and Treatment 90, 233-239.
40. Sparreboom A., Cox M.C., Acharya M.R. & Figg W.D. (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. Journal of Clinical Oncology 22, 2489-2503.
41. Spielberger C.D., Gorsuch R.L., Lushene R., Vagg P.R. & Jacobs G.A. (1983) Manual for the State-Trait Anxiety Inventory (Form Y1-Y2). Consulting Psychology Press, Palo Alto, CA, USA.
42. Thomas K. & Coleman P. (2004) Use of complementary or alternative medicine in a general population in Great Britain. Results from the National Omnibus survey. Journal of Public Health 26, 152-157.
43. Thomas K.J., Nicholl J.P. & Coleman P. (2001) Use and expenditure on complementary medicine in England: a population based survey. Complementary Therapies in Medicine 9, 2-11.
44. Van de Creek L., Rogers E. & Lester J. (1999) Use of alternative therapies among breast cancer outpatients compared with the general population. Alternative Therapies in Health and Medicine 5, 71-76.
45. Wallston B.S., Wallston K.A., Kaplan G.D. & Maides S.A. (1976) Development and validation of the health locus of control (HLO) Scale. Journal of Consulting and Clinical Psychology 44, 580-585.
46. Werneke U., Earl J., Seydel C., Horm O., Critchton P. & Fannon D. (2004) Potential health risks of complementary alternative medicines in cancer patients. British Journal of Cancer 90, 408-413.
47. Winnick T.A. (2005) From quackery to 'complementary' medicine: the American medical profession confronts alternative therapies. Social Problems 52, 38-61.